Ligand Pharmaceuticals Incorporated · NASDAQ:LGND
Aryeh Jason sold 3,000 Ligand Pharmaceuticals Incorporated shares (Form 4)
Traded Nov 10, 2026 · Filed Nov 12, 2026
On Nov 10, 2026, Aryeh Jason (Director) sold 3,000 Ligand Pharmaceuticals Incorporated shares at an average US$320.05 for US$960K, leaving 105,476 shares. Filed Nov 12, 2026 (Form 4).
- Sold
- 3,000 shares
- Price
- US$320.05 average (US$319.99 to US$320.20)
- Value
- US$960K
- Holding after
- 105,476 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock | Sale | 500 | US$319.99 | 107,976 | Direct |
| Nov 10, 2026 | Common Stock | Sale | 844 | US$320.00 | 107,132 | Direct |
| Nov 10, 2026 | Common Stock | Sale | 646 | US$320.00 | 106,486 | Direct |
| Nov 10, 2026 | Common Stock | Sale | 10 | US$320.02 | 106,476 | Direct |
| Nov 10, 2026 | Common Stock | Sale | 500 | US$320.10 | 105,976 | Direct |
| Nov 10, 2026 | Common Stock | Sale | 500 | US$320.20 | 105,476 | Direct |
Source
Download original · View original at SEC
Related
- Ligand Pharmaceuticals Incorporated
- Aryeh Jason
- Ligand Pharmaceuticals Incorporated shareholders
- Form 4 · Aryeh Jason · Nov 6, 2026
- Form 4 · Aryeh Jason · Nov 3, 2026
- Form 4 · Aryeh Jason · Jun 12, 2026
- Form 4 · Kozarich John W · Nov 16, 2026
- Form 4 · Zimmermann Martine · Nov 16, 2026
- Schedule 13G/A · Janus Henderson Group Ltd. · Nov 16, 2026
- Schedule 13G/A · Invesco Ltd. · Nov 10, 2026
- Form 4 · Reardon Andrew · Nov 4, 2026